Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
1
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
2011-06-13

Cannabinoids classically act via CB? and CB? receptors to modulate nociception; however, recent findings suggest that some cannabinoids bind to atypical receptors. One such receptor is GPR55 which is activated by the abnormal cannabidiol analogue O-1602. This study investigated whether the ...

PubMed

2
Neuroprotective antioxidants from marijuana.
2000-01-01

Cannabidiol and other cannabinoids were examined as neuroprotectants in rat cortical neuron cultures exposed to toxic levels of the neurotransmitter, glutamate. The psychotropic cannabinoid receptor agonist delta 9-tetrahydrocannabinol (THC) and cannabidiol, (a non-psychoactive constituent of marijuana), both reduced NMDA, AMPA and ...

PubMed

3
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
2008-05-12

Background and purpose:Cannabidiol is a Cannabis-derived non-psychotropic compound that exerts a plethora of pharmacological actions, including anti-inflammatory, neuroprotective and antitumour effects, with potential therapeutic interest. However, the actions of cannabidiol in the digestive tract are largely unexplored. In the present study, we ...

PubMed Central

4
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
2010-03-26

BackgroundMicroglia provide continuous immune surveillance of the CNS and upon activation rapidly change phenotype to express receptors that respond to chemoattractants during CNS damage or infection. These activated microglia undergo directed migration towards affected tissue. Importantly, the molecular species of chemoattractant encountered determines if microglia respond ...

PubMed Central

5
Cannabidiol and (?)?9-tetrahydrocannabinol are neuroprotective antioxidants
1998-07-07

The neuroprotective actions of cannabidiol and other cannabinoids were examined in rat cortical neuron cultures exposed to toxic levels of the excitatory neurotransmitter glutamate. Glutamate toxicity was reduced by both cannabidiol, a nonpsychoactive constituent of marijuana, and the psychotropic cannabinoid ...

PubMed Central

6
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
1998-07-01

The neuroprotective actions of cannabidiol and other cannabinoids were examined in rat cortical neuron cultures exposed to toxic levels of the excitatory neurotransmitter glutamate. Glutamate toxicity was reduced by both cannabidiol, a nonpsychoactive constituent of marijuana, and the psychotropic cannabinoid (-)Delta9-tetrahydrocannabinol (THC). ...

PubMed

7
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
2010-03-01

Background and purpose:We aimed to demonstrate the involvement of 5-HT1A receptors in the therapeutic effect of cannabidiol, a non-psychoactive constituent of Cannabis sativa, in a model of hepatic encephalopathy induced by bile-duct ligation (BDL) in mice.Experimental approach:Cannabidiol (5 ...

PubMed Central

8
Endocannabinoid system dysfunction in mood and related disorders.
2011-03-09

Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Objective:? The endocannabinoid (EC) system is widely distributed throughout the brain and modulates many functions. It is involved in mood and related disorders, and its activity may be modified by exogenous cannabinoids. This article examines the therapeutic potential of cannabinoids in psychiatric disorders. ...

PubMed

9
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
2009-11-13

Although cannabinoids exhibit a broad variety of anticarcinogenic effects, their potential use in cancer therapy is limited by their psychoactive effects. Here we evaluated the impact of cannabidiol, a plant-derived non-psychoactive cannabinoid, on cancer cell invasion. Using Matrigel invasion assays we found a cannabidiol-driven impaired invasion of human ...

PubMed

10
Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
2007-01-01

Oleamide (cis-9,10-octadecenoamide), a fatty acid primary amide discovered in the cerebrospinal fluid of sleep-deprived cats, has a variety of actions that give it potential as a signaling molecule, although these actions have not been extensively investigated in the cardiovascular system. The synthetic pathway probably involves synthesis of oleoylglycine and then conversion to oleamide by ...

PubMed

11
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
2004-04-01

The endothelium-dependent mesenteric vasorelaxant effect of anandamide has been attributed to stimulation of a Gi/Go-coupled receptor, for which the nonpsychoactive analog abnormal cannabidiol (abn-cbd, (-)-4-(3-3,4-trans-p-menthadien-[1,8]-yl)olivetol) is a selective agonist and the compound O-1918 ...

PubMed

12
Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia.
2011-03-31

Cannabidiol is a non-psychoactive phytocannabinoid which, based on several previous preclinical and clinical reports, is purported to have antipsychotic potential. The purpose of this investigation was to further investigate if these effects would be seen using an MK-801-induced rat model of aspects of schizophrenia. MK-801 is an NMDA receptor-antagonist ...

PubMed

13
Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure.
2011-07-19

Abstract The objective of our study was to examine the pharmacology of the intraocular pressure (IOP)-lowering actions of the behaviorally inactive cannabinoids, abnormal cannabidiol (abn-CBD), and a cannabigerol analog, cannabigerol-dimethyl heptyl (CBG-DMH), in comparison to that of the nonselective cannabinoid 1 receptor (CB(1)R) ...

PubMed

14
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
2008-08-01

This study aimed to give a rationale for the employment of phytocannabinoid formulations to treat neuropathic pain. It was found that a controlled cannabis extract, containing multiple cannabinoids, in a defined ratio, and other non-cannabinoid fractions (terpenes and flavonoids) provided better antinociceptive efficacy than the single cannabinoid given alone, when tested in a rat model of ...

PubMed

15
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
2011-01-14

Oxidative stress with reactive oxygen species generation is a key weapon in the arsenal of the immune system for fighting invading pathogens and initiating tissue repair. If excessive or unresolved, however, immune-related oxidative stress can initiate further increasing levels of oxidative stress that cause organ damage and dysfunction. Targeting oxidative stress in various diseases ...

PubMed

16
Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors.
2010-12-21

Cannabidiol (CBD) is a major non-psychotropic constituent of Cannabis sativa, with well recognized therapeutic potential. Considering the importance of the endogenous cannabinoid system to the regulation of food intake and energy balance we studied the effects of repeated CBD administration on body weight gains in rats. Male Wistar rats (260 � 20 g at start of study) ...

PubMed

17
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
2010-01-06

The cannabinoid 1 (CB(1)) and cannabinoid 2 (CB(2)) receptor agonist Delta(9)-tetrahydrocannabinol (THC) has been shown to be a broad-range inhibitor of cancer in culture and in vivo, and is currently being used in a clinical trial for the treatment of glioblastoma. It has been suggested that other plant-derived cannabinoids, which do not interact efficiently with CB(1) and ...

PubMed

18
Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.
2010-03-26

Loss of inhibitory synaptic transmission within the dorsal horn of the spinal cord plays a key role in the development of chronic pain following inflammation or nerve injury. Inhibitory postsynaptic transmission in the adult spinal cord involves mainly glycine. Ajulemic acid and HU210 are non-psychotropic, synthetic cannabinoids. Cannabidiol is a non-psychotropic plant ...

PubMed

19
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.
2006-08-17

Brain endothelial cells infection represents one of the first events in the pathogenesis of TMEV-induced demyelination disease (TMEV-IDD), a model of multiple sclerosis (MS). The fact that cyclooxygenase-2 (COX-2) expression in brain endothelium mediates a wide variety of actions during CNS inflammatory diseases such as MS, and that cannabinoids ameliorate the progression of TMEV-IDD, lead us to ...

PubMed

20
The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
2010-02-16

The effect of the plant-derived nonpsychotropic cannabinoid, cannabidiol (CBD), on the function of hydroxytryptamine (5-HT)3A receptors expressed in Xenopus laevis oocytes was investigated using two-electrode voltage-clamp techniques. CBD reversibly inhibited 5-HT (1 microM)-evoked currents in a concentration-dependent manner (IC50 = 0.6 microM). CBD (1 ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
21
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability.
2000-12-15

In the present study, the effects of the combination of tamoxifen ((Z)-2[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylamine citrate) and three cannabinoids (Delta(9)-tetrahydrocannabinol [Delta(9)-THC], cannabidiol, and anandamide [AEA]) upon the viability of C6 rat glioma cells was assessed at different incubation times and using different culturing concentrations of foetal ...

PubMed

22
Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin-seeking and normalizes discrete mesolimbic neuronal disturbances
2009-11-25

There remains debate regarding the impact of cannabis on neuropsychiatric disorders. Here, we examined the effects of cannabidiol (CBD), a nonpsychoactive constituent of cannabis on heroin self-administration and drug-seeking behavior using an experimental rat model. CBD (5-20 mg/kg) did not alter stable intake of heroin self-administration, extinction behavior, or drug ...

PubMed Central

23
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.
2011-01-14

?9-THC is a component of Cannabis sativa that increases food intake in animals and humans, an effect prevented by selective CB1 receptor antagonists. Cannabidiol (CBD) is another constituent of this plant that promotes several opposite neuropharmacological effects compared to ?9-THC. CBD mechanisms of action are still not clear, but under specific ...

PubMed

24
Tourette Syndrome: Frequently Asked Questions

... be abnormal activity of the receptor for this chemical as well. Undoubtedly, ... their onset. No blood analysis or other type of neurological testing exists to ...

MedlinePLUS

25
The Role of PRIP in Breast Cancer
2004-07-01

... an important role in the breast cancer development. ... SENSE ORGANS, RECEPTOR SITES(PHYSIOLOGY), ABNORMALITIES, MAMMARY GLANDS ...

DTIC Science & Technology

26
The Cellular Targets Estrogen in Mammary Ductal ...
2001-06-01

... pathway in estrogen effects on ductal development. ... BIOLOGY), RECEPTOR SITES(PHYSIOLOGY), ABNORMALITIES, MAMMARY GLANDS ...

DTIC Science & Technology

27
Mouse Models of the Neu Ligand Interaction with its Receptor ...
1996-07-01

... mammary adenocarcinomas in a stochastic fashion, develop Harderian gland hyperplasia and have subtle developmental abnormalities of the ...

DTIC Science & Technology

28
Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance
1999-01-01

BACKGROUND: Chronic orthostatic intolerance (OI) is characterized by symptoms of inadequate cerebral

NASA Technical Reports Server (NTRS)

29
Aberrant Chromatin Modification as a Mechanism of Prostate ...
2002-06-01

... SENSE ORGANS, RECEPTOR SITES(PHYSIOLOGY), ABNORMALITIES, GROWTH(PHYSIOLOGY), ACETYLATION, ANDROGENS, HISTONES. ...

DTIC Science & Technology

30
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.
2010-05-08

Activation of 5-HT1A receptors in the dorsal periaqueductal gray (dPAG) impairs escape behavior, suggesting a panicolytic-like effect. Cannabidiol (CBD), a major non-psychotomimetic compound present in Cannabis sativa, causes anxiolytic-like effects after intra-dPAG microinjections by activating 5-HT1A receptors. In the present work we ...

PubMed

31
Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors.
2010-09-01

Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis sativa plant that inhibits behavioral and cardiovascular responses to aversive situations, facilitating 5-HT1A-mediated neurotransmission. Previous results from our group suggest that the bed nucleus of the stria terminalis (BNST) may be involved in CBD's anti-aversive effects. To investigate whether the ...

PubMed

32
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
2009-01-01

Background and purposeCannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa which induces anxiolytic- and antipsychotic-like effects in rodents. These effects could be mediated by facilitation of the endocannabinoid system or by the activation of 5-HT1A receptors. As either of these mechanisms could promote ...

PubMed Central

33
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: ?9-tetrahydrocannabinol, cannabidiol and ?9-tetrahydrocannabivarin
2007-09-10

Cannabis sativa is the source of a unique set of compounds known collectively as plant cannabinoids or phytocannabinoids. This review focuses on the manner with which three of these compounds, (?)-trans-?9-tetrahydrocannabinol (?9-THC), (?)-cannabidiol (CBD) and (?)-trans-?9-tetrahydrocannabivarin ...

PubMed Central

34
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
2010-03-17

BackgroundDespite the frequency of diabetes mellitus and its relationship to diabetic peripheral neuropathy (DPN) and neuropathic pain (NeP), our understanding of underlying mechanisms leading to chronic pain in diabetes remains poor. Recent evidence has demonstated a prominent role of microglial cells in neuropathic pain states. One potential therapeutic option gaining clinical acceptance is the ...

PubMed Central

35
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
2010-03-15

Diabetic retinopathy is a leading cause of blindness among working-age adults. Despite many years of research, treatment options for diabetic retinopathy remain limited and with adverse effects. Discovery of new molecular entities with adequate clinical activity for diabetic retinopathy remains one of the key research priorities in ophthalmology. This review is focused on the therapeutic effects ...

PubMed Central

36
Regulation of EGF Receptor Signaling by Histone Deacetylase 6 (HDAC6)- Mediated Reversible Acetylation.
2005-01-01

One of the hallmarks of cancer is uncontrolled cell growth and proliferation. In cells, a group of proteins called growth factor receptors are responsible for responding to the signals that trigger proliferation. When these receptors function abnormally d...

National Technical Information Service (NTIS)

37
Pharmacological Characterization of GPR55, A Putative Cannabinoid Receptor
2010-03-16

GPR55 has recently attracted much attention as another member of the cannabinoid family, potentially explaining physiological effects that are non-CB1/CB2 mediated. However, the data gathered so far are conflicting with respect to its pharmacology. We review the primary literature to date on GPR55, describing its discovery, structure, pharmacology and potential physiological functions. The CB1 ...

PubMed Central

38
Cannabidiol potentiates ?(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
2011-06-11

RATIONALE: The interactions between ?(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) during chronic treatment, and at equivalent doses, are not well characterised in animal models. OBJECTIVES: The aim of this study is to examine whether the behavioural effects of THC, and blood and brain THC levels are affected by pre-treatment with equivalent CBD doses. METHODS: ...

PubMed

39
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors.
2010-07-01

Cannabidiol (CBD) is a major non-psychotomimetic component of Cannabis sativa that has been shown to have an anxiolytic effect in human and animal models. Earlier studies suggest that these effects involve facilitation of serotonin, a neurotransmitter that has also been related to obsessive-compulsive disorder. On the basis of this evidence, this study investigated the effects ...

PubMed

40
The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes
2010-05-01

The effect of the plant-derived nonpsychotropic cannabinoid, cannabidiol (CBD), on the function of hydroxytryptamine (5-HT)3A receptors expressed in Xenopus laevis oocytes was investigated using two-electrode voltage-clamp techniques. CBD reversibly inhibited 5-HT (1 ?M)-evoked currents in a concentration-dependent manner ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
41
Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
2011-04-06

?? tetrahydrocannabinol (THC) and cannabidiol (CBD) are the principal psychoactive and nonpsychoactive components of cannabis. While most THC-induced behavioral effects are thought to depend on endogenous cannabinoid 1 (CB1) receptors, the molecular targets for CBD remain unclear. Here, we report that CBD and THC inhibited the function of human 5-HT(3A) ...

PubMed

42
A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats
2010-06-25

Background and purpose:Intravenous injection of the endocannabinoid anandamide induces complex cardiovascular changes via cannabinoid CB1, CB2 and vanilloid TRPV1 receptors. Recently, evidence has been accumulating that in vitro, but not in vivo, anandamide relaxes blood vessels, via an as yet unidentified, ...

PubMed Central

43
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats.
2011-08-16

Patients with post-traumatic stress disorder (PTSD) frequently complain of having sleep disturbances, such as insomnia and rapid eye movement (REM) sleep abnormality. Cannabidiol (CBD), a psycho-inactive constituent of marijuana, reduces physiological non-REM (NREM) sleep and REM sleep in normal rats, in addition to generating its anxiolytic effect. ...

PubMed

44
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs.
2011-09-01

Newborn piglets exposed to acute hypoxia-ischemia (HI) received i.v. cannabidiol (HI + CBD) or vehicle (HI + VEH). In HI + VEH, 72 h post-HI brain activity as assessed by amplitude-integrated EEG (aEEG) had only recovered to 42 � 9% of baseline, near-infrared spectroscopy (NIRS) parameters remained lower than normal, and neurobehavioral performance was ...

PubMed

45
The Profile of Immune Modulation by Cannabidiol (CBD) Involves Deregulation of Nuclear Factor of Activated T Cells (NFAT)
2008-07-08

Cannabidiol (CBD) is a cannabinoid compound derived from Cannabis Sativa that does not possess high affinity for either the CB1 or CB2 cannabinoid receptors. Similar to other cannabinoids, we demonstrated previously that CBD suppressed interleukin-2 (IL-2) production from phorbol ester plus calcium ionophore (PMA/Io)-activated murine splenocytes. Thus, the ...

PubMed Central

46
Effect of cannabinoids on the binding of /sup 3/H-(3-MeHis/sup 2/)TRH to rat brain membranes
1986-03-05

Cannabinoids, particularly ..delta../sup 9/-THC is known to affect thyroid function. The effect of naturally occurring and synthetic cannabinoids on brain TRH receptors labeled with /sup 3/H-(3-MeHis/sup 2/)TRH(MeTRH) was determined. /sup 3/H-MeTRH bound to brain membranes at a single high affinity binding sites with a B/sub max/ of 48 +/- 2 fmol/mg protein and K/sub d/ of 4.2 ...

Energy Citations Database

47
Cannabinoids ?9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-?B and Interferon-?/STAT Proinflammatory Pathways in BV-2 Microglial Cells*
2010-01-15

Cannabinoids have been shown to exert anti-inflammatory activities in various in vivo and in vitro experimental models as well as ameliorate various inflammatory degenerative diseases. However, the mechanisms of these effects are not completely understood. Using the BV-2 mouse microglial cell line and lipopolysaccharide (LPS) to induce an inflammatory response, we studied the signaling pathways ...

PubMed Central

48
Cannabidiol enhances the inhibitory effects of ?9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
2010-01-06

The cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor agonist, ?9-tetrahydrocannabinol (THC), has been shown to be a broad range inhibitor of cancer in culture and in vivo, and is currently being used in a clinical trial for the treatment of glioblastoma. It has been suggested that other plant-derived ...

PubMed Central

49
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In VivoS?

Plant-derived cannabinoids (phytocannabinoids) are compounds with emerging therapeutic potential. Early studies suggested that cannabidiol (CBD) has anticonvulsant properties in animal models and reduced seizure frequency in limited human trials. Here, we examine the antiepileptiform and antiseizure potential of CBD ...

PubMed Central

50
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
2010-01-04

Background and purpose:Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that induces anxiolytic- and antipsychotic-like effects in animal models. Effects of CBD may be mediated by the activation of 5-HT1A receptors. As 5-HT1A receptor activation may induce ...

PubMed Central

51
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.
2011-08-26

RATIONALE: Cannabidiol, the main nonpsychotropic constituent of Cannabis sativa, possesses a large number of pharmacological effects including anticonvulsive, sedative, hypnotic, anxiolytic, antipsychotic, anti-inflammatory, and neuroprotective, as demonstrated in clinical and preclinical studies. Many neurodegenerative disorders involve cognitive deficits, and this has led to ...

PubMed

52
DNA encoding SNORF33 receptor
2006-01-17

This invention provides isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, vectors comprising nucleic acid encoding mammalian SNORF33 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF33 receptors, nucleic acid probes useful for detecting ...

US Patent & Trademark Office Database

53
NIH.R1 Kennedy Space Center (KSC) - Life Sciences Data Archive

Apr 21, 2011 ... + Development of Sensory Receptors in Skeletal Muscle (9303006) + Developmental Abnormalities (PARE.04C) ...

NASA Website

54
Measles Virus Nucleocapsid (MVNP) Gene Expression and ...
2008-10-01

... 8q24.2 that encodes osteoprotegerin (OPG), a member of the tumor necrosis factor receptor family [5]. The primary pathologic abnormality in ...

DTIC Science & Technology

55
Life Sciences Data Archive: Data Sets

Apr 21, 2011 ... + Development of Sensory Receptors in Skeletal Muscle (9303006) + Developmental Abnormalities (PARE.04C) + Effect of Microgravity on ...

NASA Website

56
Antioxidant Prophylaxis in the Prevention of Prostatic ...
2007-02-01

... group were found to have gross abnormalities in kidney, bladder, seminal ... expression of hepatocyte growth factor and its receptor, c-Met, during sex ...

DTIC Science & Technology

57
Abnormal Interleukin-1 Receptor Type II Gene Expression in the Endometrium of Women with Endometriosis1

... antibody, and fluorescein isothiocyanate-conjugated streptavidin, ... and B2). Note the greater number of hybridization signals in a part of an ... ...

NBII National Biological Information Infrastructure

58
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
2011-04-01

BackgroundMyeloid-derived suppressor cells (MDSCs) are getting increased attention as one of the main regulatory cells of the immune system. They are induced at sites of inflammation and can potently suppress T cell functions. In the current study, we demonstrate how activation of TRPV1 vanilloid receptors ...

PubMed Central

59
The discovery of a cannabinoid receptor
1989-01-01

A tritiated form of CP-55,940, a Pfizer cannabinoid analog that is 20- to 100-fold more potent than {Delta}{sup 9}-tetrahydrocannabinol in various in vivo and in vitro models of cannabimimetric activity, was used as the tool with which to probe for a cannabinoid receptor in rat cortical membranes. The bound and free ligand were successfully separated using a centrifugation ...

Energy Citations Database

60
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
2009-12-02

Cannabinoids play an important role in activity-dependent changes in synaptic activity and can interfere in several brain functions, including responses to aversive stimuli. The regions responsible for their effects, however, are still unclear. Cannabinoid type 1 (CB1) receptors are widely distributed in the central nervous system and are present in the periaqueductal gray ...

PubMed Central

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
61
Symptom-relieving and neuroprotective effects of the phytocannabinoid ?(9) -THCV in animal models of Parkinson's disease.
2011-08-01

BACKGROUND AND PURPOSE Previous findings have indicated that a cannabinoid, such as ?(9) -THCV, which has antioxidant properties and the ability to activate CB(2) receptors but to block CB(1) , might be a promising therapy for alleviating symptoms and delaying neurodegeneration in Parkinson's disease (PD). EXPERIMENTAL APPROACH The ability of ?(9) -THCV to reduce motor ...

PubMed

62
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
2009-02-01

Medicines that activate cannabinoid CB1 and CB2 receptor are already in the clinic. These are Cesamet� (nabilone), Marinol� (dronabinol; ?9-tetrahydrocannabinol) and Sativex� (?9-tetrahydrocannabinol with cannabidiol). The first two of these medicines can be ...

PubMed Central

63
Endothelial Cell Specific Receptor TIE-2 as a Therapeutic Target.
1999-01-01

Angiopoietin-1 (Ang-1) and its receptor Tie-2, a trans-membrane tyrosine kinase uniquely expressed by endothelial cells, are essential to developmental angiogenesis. The phenotypic abnormalities shown by null mutation studies suggest that Tie-2 signaling ...

National Technical Information Service (NTIS)

64
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
2011-09-14

The therapeutic potential of cannabidiol, the major non-psychotropic Cannabis constituent, was investigated in rats exposed to ischemia/reperfusion liver injury. Ischemia was induced by clamping the pedicle of the left hepatic lobe for 30min, and cannabidiol (5mg/kg, i.v.) was given 1h following the procedure and every 24h thereafter for 2days. ...

PubMed

65
The effects of ?9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
2010-06-01

Background and purpose:Cannabis is taken as self-medication by patients with inflammatory bowel disease for symptomatic relief. Cannabinoid receptor agonists decrease inflammation in animal models of colitis, but their effects on the disturbed motility is not known. (-)-Cannabidiol (CBD) has been shown to interact with ...

PubMed Central

66
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus.
2010-11-16

Indian hemp is used since thousands of years as herbal drug. We found that a single dose of cannabis resin was equally active as ?9-tetrahydrocannabinol (THC) enhancing severity and duration of symptoms in vaccinia virus infected mice. Cowpox virus did not cause symptomatic disease, but some reduction of specific antibody production was observed in drug treated animals. In vitro cannabis was ...

PubMed

67
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
2011-03-11

Ischemia/reperfusion (I/R) is a pivotal mechanism of liver damage after liver transplantation or hepatic surgery. We have investigated the effects of cannabidiol (CBD), the nonpsychotropic constituent of marijuana, in a mouse model of hepatic I/R injury. I/R triggered time-dependent increases/changes in markers of liver injury (serum transaminases), hepatic oxidative/nitrative ...

PubMed

68
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
2011-08-01

BACKGROUND AND PURPOSE Cannabis extracts and several cannabinoids have been shown to exert broad anti-inflammatory activities in experimental models of inflammatory CNS degenerative diseases. Clinical use of many cannabinoids is limited by their psychotropic effects. However, phytocannabinoids like cannabidiol (CBD), devoid of psychoactive activity, are, potentially, safe and ...

PubMed

69
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
2011-05-12

Cannabidiol (CBD), a major nonpsychoactive constituent of cannabis, is considered an antineoplastic agent on the basis of its in vitro and in vivo activity against tumor cells. However, the exact molecular mechanism through which CBD mediates this activity is yet to be elucidated. Here, we have shown CBD-induced cell death of breast cancer cells, independent of cannabinoid and ...

PubMed

70
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
2011-06-09

The major cellular event in the development and progression of liver fibrosis is the activation of hepatic stellate cells (HSCs). Activated HSCs proliferate and produce excess collagen, leading to accumulation of scar matrix and fibrotic liver. As such, the induction of activated HSC death has been proposed as a means to achieve resolution of liver fibrosis. Here we demonstrate that ...

PubMed

71
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
2011-06-09

The major cellular event in the development and progression of liver fibrosis is the activation of hepatic stellate cells (HSCs). Activated HSCs proliferate and produce excess collagen, leading to accumulation of scar matrix and fibrotic liver. As such, the induction of activated HSC death has been proposed as a means to achieve resolution of liver fibrosis. Here we demonstrate that ...

PubMed Central

72
The growth receptors and their role in wound healing.
2010-11-01

Abnormal wound healing is a major problem in healthcare today, with both scarring and chronic wounds affecting large numbers of individuals worldwide. Wound healing is a complex process involving several variables, including growth factors and their receptors. Chronic wounds fail to complete the wound healing process, while scarring is considered to be an ...

PubMed

73
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
2010-06-17

BackgroundAdult neurogenesis is a particular example of brain plasticity that is partially modulated by the endocannabinoid system. Whereas the impact of synthetic cannabinoids on the neuronal progenitor cells has been described, there has been lack of information about the action of plant-derived extracts on neurogenesis. Therefore we here focused on the effects of ?9-tetrahydrocannabinol (THC) ...

PubMed Central

74
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
2011-07-05

Background? This study was to investigate the effects of the novel cannabinoid receptor - G protein-coupled receptor 55 (GPR55) - and its ligands O-1602 and cannabidiol (CBD) on gastrointestinal (GI) motility in rodents. Methods? Lipopolysaccharide (LPS) was used in vivo to produce the model of septic ileus. The intestinal motility was ...

PubMed

75
Study of the Regulation of erbB Signaling by Receptor-mediated Endocytosis.
2000-01-01

Endocytosis of erbB receptors is an important regulator of erbB receptor signaling. Given that abnormal erbB signaling may lead to cellular transformation, it is important to understand the factors that determine its regulation. ErbB-2, the erbB receptor ...

National Technical Information Service (NTIS)

76
Promoter variants of the alpha-7 nicotinic acetylcholine receptor
2009-08-11

The present invention is directed to methods and compositions related to .alpha.7 acetylcholine nicotinic receptor genes, in particular, the human .alpha.7 nicotinic acetylcholine receptor gene. The human .alpha.7 nicotinic acetylcholine receptor gene is associated with the pathophysiological aspects of the disease schizophrenia. The ...

US Patent & Trademark Office Database

77
Prospects for cannabinoid therapies in basal ganglia disorders.
2011-08-01

Cannabinoids are promising medicines to slow down disease progression in neurodegenerative disorders including Parkinson's disease (PD) and Huntington's disease (HD), two of the most important disorders affecting the basal ganglia. Two pharmacological profiles have been proposed for cannabinoids being effective in these disorders. On the one hand, cannabinoids like ?(9) -tetrahydrocannabinol or ...

PubMed

78
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
2010-03-01

Delta(9)-Tetrahydrocannabinol (Delta(9)-THC), the principal psychoactive constituent of the Cannabis sativa plant, and other agonists at the central cannabinoid (CB(1)) receptor may induce characteristic psychomotor effects, psychotic reactions and cognitive impairment resembling schizophrenia. These effects of Delta(9)-THC can be reduced in animal and human models of ...

PubMed

79
Cannabinoid ligand-receptor signaling in the mouse uterus.
1995-05-09

Using RNA (Northern) blot hybridization and reverse transcription-PCR, we demonstrate that the brain-type cannabinoid receptor (CB1-R) mRNA, but not the spleen-type cannabinoid receptor (CB2-R) mRNA, is expressed in the mouse uterus and that this organ has the capacity to synthesize the putative endogenous cannabinoid ligand, anandamide ...

PubMed Central

80
Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
2008-04-07

Delta(9)-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most prevalent biologically active constituents of Cannabis sativa. THC is the prototypic cannabinoid CB1 receptor agonist and is psychoactive and analgesic. CBD is also analgesic, but it is not a CB1 receptor agonist. Low voltage-activated T-type calcium channels, ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
81
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus.
2011-08-01

Background and purpose: To evaluate the hypothesis that agonism of somatodentdritic 5-HT(1A) autoreceptors in the Dorsal Raphe Nucleus (DRN) produces the anti-emetic/anti-nausea effects of cannabidiol (CBD), a primary non-psychoactive cannabinoid found in cannabis. Experimental approach: The potential of systemic and intra-DRN administration of 5-HT(1A) ...

PubMed

82
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.
2006-07-01

Cannabis extracts and synthetic cannabinoids are still widely considered illegal substances. Preclinical and clinical studies have suggested that they may result useful to treat diverse diseases, including those related with acute or chronic pain. The discovery of cannabinoid receptors, their endogenous ligands, and the machinery for the synthesis, transport, and degradation ...

PubMed

83
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
2006-07-01

Cannabis extracts and synthetic cannabinoids are still widely considered illegal substances. Preclinical and clinical studies have suggested that they may result useful to treat diverse diseases, including those related with acute or chronic pain. The discovery of cannabinoid receptors, their endogenous ligands, and the machinery for the synthesis, transport, and degradation ...

PubMed Central

84
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.
2011-01-23

Adenosine, dopamine and endocannabinoids strictly modulate the release of one another in the dorsolateral striatum thereby controlling synaptic plasticity. As a second level of interaction, they regulate the action of one another via receptor heteromer formation. Here we investigated a putative third level of interaction, i.e. the possible control by cannabinoids of synaptic ...

PubMed

85
Detection of a frequent restriction fragment length polymorphism in the human T cell antigen receptor beta chain locus. A potential diagnostic tool.
1985-09-01

Abnormal T cell function is a feature of a spectrum of inherited and acquired diseases. We have detected a frequent restriction fragment length polymorphism in the human T cell antigen receptor beta-chain locus that may aid in the analysis of these disorders. A study of a panel of 18 normal individuals, testing for the presence of the polymorphism, showed ...

PubMed Central

86
ODA Commodity Inspection Division Industrial hemp in Oregon
2011-09-25

(THC) and high in cannabidiol (CBD). Is industrial hemp the same as marijuana? No. Both are varieties of Cannabis sativa L., but marijuana is high in THC and low...

Science.gov Websites

87
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor. beta
1989-11-01

The syndrome of generalized resistance to thyroid hormone is characterized by elevated circulating levels of thyroid hormone in the presence of an overall eumetabolic state and failure to respond normally to triiodothyronine. The authors have evaluated a family with inherited generalized resistance to thyroid hormone for abnormalities in the thyroid hormone nuclear ...

Energy Citations Database

88
Generalized Resistance to Thyroid Hormone Associated with a Mutation in the Ligand-Binding Domain of the Human Thyroid Hormone Receptor ?
1989-11-01

The syndrome of generalized resistance to thyroid hormone is characterized by elevated circulating levels of thyroid hormone in the presence of an overall eumetabolic state and failure to respond normally to triiodothyronine. We have evaluated a family with inherited generalized resistance to thyroid hormone for abnormalities in the thyroid hormone nuclear ...

NASA Astrophysics Data System (ADS)

89
Evidence that the plant cannabinoid cannabigerol is a highly potent ?2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist
2010-01-04

Background and purpose:Cannabis is the source of at least seventy phytocannabinoids. The pharmacology of most of these has been little investigated, three notable exceptions being ?9-tetrahydrocannabinol, cannabidiol and ?9-tetrahydrocannabivarin. This investigation addressed the question of whether the little-studied ...

PubMed Central

90
Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor ?
2002-01-01

Blood vessels express estrogen receptors, but their role in cardiovascular physiology is not well understood. We show that vascular smooth muscle cells and blood vessels from estrogen receptor ? (ER?)-deficient mice exhibit multiple functional abnormalities. In wild-type mouse blood vessels, estrogen attenuates vasoconstriction by an ...

NASA Astrophysics Data System (ADS)

91
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
2009-08-12

Considerable preclinical research has demonstrated the efficacy of Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the primary psychoactive constituent of Cannabis sativa, in a wide variety of animal models of pain, but few studies have examined other phytocannabinoids. Indeed, other plant-derived cannabinoids, including cannabidiol (CBD), cannabinol (CBN), and cannabichromene ...

PubMed

92
P2 receptors in renal pathophysiology.
2009-06-09

Our knowledge and understanding of the P2 receptor signalling system in the kidney have increased significantly in the last ten years. The broad range of physiological roles proposed for this receptor system and the variety of P2 receptor subtypes found in the kidney suggest that any disturbance of function may contribute to several ...

PubMed

93
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
2011-02-24

Microglial activation is an invariant feature of Alzheimer's disease (AD). It is noteworthy that cannabinoids are neuroprotective by preventing ?-amyloid (A?)-induced microglial activation both in vitro and in vivo. On the other hand, the phytocannabinoid cannabidiol (CBD) has shown anti-inflammatory properties in different paradigms. In the present study, we compared the ...

PubMed

94
Estrogen Receptor Signaling and Its Relationship to Cytokines in Systemic Lupus Erythematosus
2010-06-10

Dysregulation of cytokines is among the main abnormalities in Systemic Lupus Erythematosus (SLE). However, although, estrogens, which are known to be involved in lupus disease, influence cytokine production, the underlying molecular mechanisms remain poorly defined. Recent evidence demonstrates the presence of estrogen receptor in various cell types of ...

PubMed Central

95
Treating Adult T-cell Leukemia/Lymphoma

In ATLL, HTLV-1 causes abnormal and uncontrolled growth of T cells (immune system cells that normally fight infections and disease). These malignant T cells often express high amounts of a protein called Tac, which is a receptor protein for the immune system hormone interleukin-2.

Cancer.gov

96
The Cause of Infertility of Male c-ros Tyrosine Kinase Receptor Knockout Mice1

... junction associated with swollen cytoplasmic droplets [5]. This defect is thought to reflect an abnormality in the ... knockout mice and wild-type males as controls. Defects in the interaction of sperm wi...

NBII National Biological Information Infrastructure

97
P/CAF Function in Transcriptional Activation by Steroid Hormone Receptors and Mammary Cell Proliferation.
1998-01-01

Inappropriate gene expression and abnormal progression of the cell cycle are intimately linked to oncogenesis and tumor formation. The purpose of this proposal is to examine the role of the PCAF histone acetyltransferase as a co-factor for steroid hormone...

National Technical Information Service (NTIS)

98
Method of Detecting and Preventing Alzheimer's Disease, Particularly at Prodromal and Early Stages
2003-01-01

A method of detecting Alzheimer's disease includes detecting a disruption or alteration in normal sub-cellular distribution of G-protein receptor kinases (GRKs), particularly GRK2 and GRK5. The disruption is caused by abnormal accumulation of soluble .bet...

National Technical Information Service (NTIS)

99
Involvement of Estrogen Receptor β in the Induction of Polyovular Follicles in Mouse Ovaries Exposed Neonatally to ...

... PubMedlguchi T, Sato T (2000) Endocrine disruption and developmental abnormalities of female reproduction. Am Zool 40: 402�411 ... ...

NBII National Biological Information Infrastructure

100
INVESTIGATING PRINCIPLES OF HUMAN BRAIN FUNCTION UNDERLYING WORKING MEMORY: WHAT INSIGHTS FROM

of abnormalities in blood flow, metabo- lism, and neurotransmitter receptor function and has the potential study that included both first-onset psychosis and chronic schizophrenic subjects as well as controls

E-print Network

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
101
Expression by Transgenesis of a Constitutively Active Mutant Form of the Prolactin Receptor Induces Premature Abnormal ...

... lines proceeded with obvious problems. A marked lactation defect was apparent in transgenic females and could be ... number (five copies). The occurrence of a lactational defect might be partially explain...

NBII National Biological Information Infrastructure

102
Delphinidin: A Novel Agent for Inhibition of Breast Tumor Kinase Signaling by Targeting EGFR.
2006-01-01

Abnormalities in the expression and signaling pathways downstream of the epidermal growth factor receptor (EGFR) contribute to the progression, invasion, and maintenance of the malignant phenotype in breast cancer. EGFR is expressed at high levels in at l...

National Technical Information Service (NTIS)

103
Cutting the head off chemokines

- tunately, in an unregulated state they can also mediate abnormal leukocyte infiltration in ARDS off by extracellular proteases. Since the amino terminus mediates receptor acti- vation, this creates), which are secreted during the inflammatory response, can specifically cleave off the amino termini

E-print Network

104
Chemotherapy for Prostate Cancer

... androgen) synthesis (i.e. abirateone) or androgen receptor inhibition (i.e. MDV3100). For patients whose disease has ... being discharged through the urethra. cancer: An abnormal growth that can invade nearby structures and spread to ...

MedlinePLUS

105
Brain imaging studies of the cocaine addict: Implications for reinforcement and addiction.
1995-01-01

These studies document dopaminergic abnormalities in cocaine abusers. They also suggest a regulatory role of Dopamine (DA) in frontal metabolism. The correlation of striatal D(sub 2) receptor availability with metabolism was strongest for orbital frontal ...

National Technical Information Service (NTIS)

106
Autoradiographic Distribution and Applied Pharmacological Characteristics of Dextromethorphan and Related Antitissue/Anticonvulsant Drugs and Novel Analogs.
1991-01-01

The objective of this project is to investigate the potential significance of the neuroprotective agent dextromethorphan, and its receptor, in normal and abnormal brain. Dextromethorphan is a non-opioid cough suppressant. It is as potent as codeine, but h...

National Technical Information Service (NTIS)

107
Cannabidiol-induced lymphopenia does not involve NKT and NK cells.
2009-10-01

The major non-psychoactive compound of cannabis plant, cannabidiol, has been reported to be a promising therapeutic agent for many inflammatory, autoimmune and neurodegenerative diseases. In spite of growing interest in therapeutic use of cannabidiol very little is known about its influence on the immune system. Present study aimed to evaluate lymphocyte ...

PubMed

108
Lack of association of the RTN4R genetic variations with risk of schizophrenia and SPEM abnormality in a Korean population.
2011-03-05

This study examined the association of the reticulon 4 receptor (RTN4R) gene with schizophrenia and smooth pursuit eye movement (SPEM) abnormality in a Korean population. Although we failed to provide convincing evidence that RTN4R is associated with schizophrenia development and SPEM impairment, our findings may be useful for further genetic studies. ...

PubMed

109
Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice

HIV infection is associated with abnormal lipid metabolism, body fat redistribution, and altered energy expenditure. The pathogenesis of these complex abnormalities is unclear. Viral protein R (Vpr), an HIV-1 accessory protein, can regulate gene transcription mediated by the glucocorticoid receptor ...

Technology Transfer Automated Retrieval System (TEKTRAN)

110
DOI: 10.1126/science.1140734 , 1347 (2007);317Science

receptor ENSTGUG00000004249 ASPM Abnormal spindle-like microcephaly-associated protein ENSTGUG00000004747 (ASPM and LHX2). In partic- ular, ASPM (abnormal spindle-like microcephaly-associ- ated) has been mutations in ASPM are a cause of primary microcephaly [77] and the gene shows evidence of positive selection

E-print Network

111
A structurally abnormal insulin causing human diabetes
1979-09-01

Insulin isolated from the pancreas of a diabetic patient with fasting hyperinsulinaemia showed decreased activity in binding to cell membrane insulin receptors and in stimulating cellular 2-deoxyglucose transport and glucose oxidation. Chemical studies suggest that the isolated hormone is a mixture of normal insulin and an abnormal variant which contains a ...

NASA Astrophysics Data System (ADS)

112
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
2009-09-22

GPR55 is a G protein-coupled receptor recently shown to be activated by certain cannabinoids and by lysophosphatidylinositol (LPI). However, the physiological role of GPR55 remains unknown. Given the recent finding that the cannabinoid receptors CB1 and CB2 affect bone metabolism, we examined the role of GPR55 ...

PubMed Central

113
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
2011-06-14

We studied whether combinations of botanical extracts enriched in either ?(9) -tetrahydrocannabinol (?(9) -THC) or cannabidiol (CBD), which are the main constituents of the cannabis-based medicine Sativex, provide neuroprotection in rat models of Huntington's disease (HD). We used rats intoxicated with 3-nitropropionate (3NP) that were given combinations of ?(9) -THC- and ...

PubMed

114
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.
2011-07-11

Background and purpose:? Activation of cannabinoid receptors decreases emesis, inflammation, gastric acid secretion and intestinal motility. The ability to modulate intestinal permeability in inflammation may be important in therapy aimed at maintaining epithelial barrier integrity. The aim of the present study was therefore to investigate the effects of cannabinoids on ...

PubMed

115
Cannabinoids in the management of difficult to treat pain
2008-02-01

This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment. Tetrahydrocannabinol (THC, Marinol) and nabilone (Cesamet) are currently approved in the United States and other countries, ...

PubMed Central

116
Insulin resistance in an infant with leprechaunism.
1984-09-01

A Japanese female infant with typical features of leprechaunism exhibited glucose intolerance despite marked hyperinsulinemia, indicating insulin resistance. Circulating insulin appeared to be chemically and biologically normal. There was no evidence of antagonism of insulin action or circulating antibodies to insulin or insulin receptors. Insulin receptor ...

PubMed

117
Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.

Human melanocytes respond to several growth factors whose receptors have tyrosine kinase activity. Abnormalities in the expression of tyrosine kinase receptors may play an important role in the initiation and progression of melanoma. We therefore determined the steady-state mRNA expression of five tyrosine kinase ...

PubMed

118
Abnormal dephosphorylation effect on NMDA receptor regulation in ALS spinal cord.
1997-01-01

Previous studies have demonstrated a significant reduction of N-methyl-D-aspartate (NMDA) receptor binding in spinal cord sections from patients who died with amyotrophic lateral sclerosis (ALS) compared to that in control patients. The reduction in NMDA receptor binding in ALS could be increased toward control values by treatment with phorbol ester, ...

PubMed

119
Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia.
1982-10-01

Synthesis of the low density lipoprotein (LDL) receptor was studied by incubation of cultured human fibroblasts with 35S-methionine followed by immunoprecipitation with a monoclonal antireceptor antibody. The receptor was synthesized as a precursor with an apparent molecular weight of 120 kilodaltons (kd) that was converted to a mature form of 160 kd. This ...

PubMed

120
Cell surface receptors in malignant glioma.
2011-10-01

Despite advances in surgery, radiation, and chemotherapy, malignant gliomas are still highly lethal tumors. Traditional treatments that rely on nonspecific, cytotoxic approaches have a marginal impact on patient survival. However, recent advances in the molecular cancer biology underlying glioma pathogenesis have revealed that abnormalities in common cell surface ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page
 
121
Androgen receptor mutations and androgen insensitivity.
2002-12-30

The androgen receptor (AR) is a high affinity receptor protein encoded on the human X-chromosome that mediates the actions of androgens during development and in the adult. Defects in this receptor protein result in a wide range of abnormalities of male sexual development. Studies in a number of different ...

PubMed

122
Sleep and Sleep Homeostasis in Mice Lacking the 5-HT2c Receptor
2002-11-01

Studies in humans and rats indicate that serotonin (5-hydroxytryptamine, 5-HT) receptors are involved in mammalian sleep expression. We investigated the contribution of the 5-HT2c receptor to sleep expression by examining sleep patterns in mice bearing a targeted null mutation of this receptor. 5-HT2c receptor ...

PubMed Central

123
B cell acute lymphoblastic leukemia (ALL) with a 14q+ chromosome abnormality
1979-02-01

An adult patient with acute lymphoblastic leukemia associated with a 14q+ marker chromosome is presented. The abnormally resulted from a translocation of material from the long arm of chromosome 11. The leukemic cells were found to be B cells on the basis of surface immunoglobulins, lack of receptors for sheep erythrocytes, and a characteristically low ...

Energy Citations Database

124
Alternative splicing and the progesterone receptor in breast cancer
2008-05-30

Progesterone receptor status is a marker for hormone responsiveness and disease prognosis in breast cancer. Progesterone receptor negative tumours have generally been shown to have a poorer prognosis than progesterone receptor positive tumours. The observed loss of progesterone receptor could be through a range of ...

PubMed Central

125
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
2010-09-07

Vascular dilatation is critically impaired in many diseases and is encountered by an upregulated endothelin receptor A (ETA) in the vasculature in association with a decline in nitric oxide bioavailability. Diabetic vasculopathy is characterized as a compromised vascular dilatation, implicated in many diabetic complications. It appears to be activated ETA and NADPH ...

PubMed Central

126
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.
2004-09-15

Although many genetic disorders are characterized by cognitive failure during development, there is little insight into the neurobiological basis for the abnormalities. Down syndrome (DS), a disorder caused by the presence of three copies of chromosome 21 (trisomy 21), is characterized by impairments in learning and memory attributable to dysfunction of the hippocampus. We ...

PubMed

127
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
1995-10-10

Using a reverse transcription-coupled PCR, we demonstrated that both brain and spleen type cannabinoid receptor (CB1-R and CB2-R, respectively) mRNAs are expressed in the preimplantation mouse embryo. The CB1-R mRNA expression was coincident with the activation of the embryonic genome late in the two-cell stage, whereas the CB2-R mRNA was present from the one-cell through the ...

PubMed Central

128
Regulation of nausea and vomiting by cannabinoids.
2011-08-01

Considerable evidence demonstrates that manipulation of the endocannabinoid system regulates nausea and vomiting in humans and other animals. The anti-emetic effect of cannabinoids has been shown across a wide variety of animals that are capable of vomiting in response to a toxic challenge. CB(1) agonism suppresses vomiting, which is reversed by CB(1) antagonism, and CB(1) inverse agonism promotes ...

PubMed

129
Phytocannabinoids as novel therapeutic agents in CNS disorders.
2011-09-01

The Cannabis sativa herb contains over 100 phytocannabinoid (pCB) compounds and has been used for thousands of years for both recreational and medicinal purposes. In the past two decades, characterisation of the body's endogenous cannabinoid (CB) (endocannabinoid, eCB) system (ECS) has highlighted activation of central CB(1) receptors by the major pCB, ...

PubMed

130
Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
2010-02-01

Cannabis sativa L. (cannabis) extracts, vapor produced by the Volcano vaporizer and smoke made from burning cannabis joints were analyzed by GC-flame ionization detecter (FID), GC-MS and HPLC. Three different medicinal cannabis varieties were investigated Bedrocan, Bedrobinol and Bediol. Cannabinoids plus other components such as terpenoids and pyrolytic by-products were identified and quantified ...

PubMed

131
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
2011-04-12

Numerous studies demonstrated a close relationship between cannabis abuse and schizophrenia with similar impairments in cognitive processing, particularly in P300 generation. Recently, an (AAT)n triplet repeat polymorphism within the cannabinoid receptor gene CNR1 has been found to be associated with both schizophrenia and substance dependence, and to modulate the P300 ...

PubMed

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page